Markets:

Overview

News

Currencies

International

Treasuries

Novartis AG Common Stock (NY:NVS)

139.25 +0.63 (+0.45%)

Streaming Delayed Price Updated: 12:53 PM EDT, Sep 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

59 60 Next >

3 Unstoppable Dividend Stocks to Buy Right Now ↗

August 12, 2023

These stocks' dividends are more dependable than most.

Via The Motley Fool

Immuno Oncology Market May See a Big Move : AstraZeneca, Bristol Myers Squibb, F. Hoffmann-La Roche

August 09, 2023

Stay up-to-date with Immuno Oncology Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Novartis's Remibrutinib Shows Rapid Improvement In Type Of Skin Disorder That Impacts 40M People ↗

August 09, 2023

Novartis AG (NYSE: NVS)

Via Benzinga

Hypertrophic Cardiomyopathy Therapeutics Market Projected to Show Strong Growth : Novartis, Gilead Sciences, ADVANZ PHARMA

August 08, 2023

Stay up-to-date with Hypertrophic Cardiomyopathy Therapeutics Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

DTx Pharma Acquisition by Novartis Generates Robust Returns for Tech Coast Angels and NuFund Venture Group

August 03, 2023

IRVINE, Calif. - Aug. 3, 2023 - PRLog -- Tech Coast Angels (TCA) and NuFund Venture Group (formerly TCA-San Diego) today announced that portfolio company DTx Pharma was acquired by Swiss pharmaceutical...

Via PRLog

Should Income Investors Buy This Blue Chip Stock? ↗

July 23, 2023

This Swiss drugmaker is one of the most dominant players in its industry.

Via The Motley Fool

Why Novartis Stock Spiked Today ↗

July 18, 2023

A massive share buyback program and an improved outlook powered a mid-single-digit rise in the drugmaker's shares today.

Via The Motley Fool

Multiple Myeloma Therapy Market Projected to Show Strong Growth : Hikma Pharmaceutical, Eagle Pharmaceuticals, Janssen Biotech

August 08, 2023

Get Multiple Myeloma Therapy Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.

Via SBWire

The Year’s Top 3 International ETFs as of August 2023 ↗

August 07, 2023

By investing in international ETFs, you can mitigate potential losses with a more diversified portfolio. Here are three with strong returns.

Via InvestorPlace

Blockbuster Drugs Market Projected to Show Strong Growth : Celgene, Bristol-Myers Squibb, Pfizer

August 03, 2023

Get an extensive Blockbuster Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.

Via SBWire

Topics Intellectual Property

7 Best Cancer Stocks to Invest in Now

July 28, 2023

The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.

Via MarketBeat

Topics Death

Novartis Ag (NVS) Q2 2023 Earnings Call Transcript ↗

July 18, 2023

NVS earnings call for the period ending June 30, 2023.

Via The Motley Fool

Novartis Puts Up Its Biggest Earnings Growth In Two Years; Shares Pop ↗

July 18, 2023

Novartis put up more than 17.3% growth in its profit, beating quarterly records since June 2021.

Via Investor's Business Daily

3 Biotech Stocks You Better Be Buying on Each and Every Dip ↗

July 27, 2023

Biotech companies can bring about life-changing innovations. We've created a list to help you find the best biotech stocks out there.

Via InvestorPlace

2 Stocks That Raised Their Guidance in July ↗

July 26, 2023

With inflation elevated, these are relatively resilient businesses to invest in.

Via The Motley Fool

Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries ↗

July 26, 2023

Seven pharmaceutical companies recently launched their biosimilars of AbbVie Inc's (NYSE: ABBV) top-selling

Via Benzinga

The 7 Best Dividend Stocks to Protect Your Portfolio From Global Chaos ↗

July 24, 2023

With global events only rising in entropy, investors ought to consider these best dividend stocks for portfolio protection.

Via InvestorPlace

AI for Pharma and Biotech Market May Set Massive Growth by 2030

July 24, 2023

Get a view on AI for Pharma and Biotech Market sales by marketing channels. Target important market by region and tap important dynamics of this industry.

Via SBWire

Topics Artificial Intelligence

Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush

July 24, 2023

A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies.

Via MarketBeat

Week In Review: Novartis In $1 Billion Deal For DTx Pharma ↗

July 22, 2023

Novartis signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing siRNA therapies for neuroscience indications. Meanwhile, Zhuhai Biotheus formed a far-reaching...

Via Talk Markets

Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review ↗

July 21, 2023

But all the major indexes are at or near 15-month highs.

Via Investor's Business Daily

FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt ↗

July 21, 2023

The FDA has approved Daiichi Sankyo's (OTC: DSNKY) Vanflyta (quizartinib) in

Via Benzinga

Why Harrow Health Stock Is Trading Higher Today? ↗

July 19, 2023

Harrow Health Inc (NASDAQ: HROW) agreed to acquire the U.S. and Canadian commercial rights for Vevye (cyclosporine ophthalmic solution) 0.1%, a non‑preserved from Novaliq GmbH.

Via Benzinga

Can Novartis Move to New Highs and Sustain Them?

July 19, 2023

Novartis stock is moving higher following outperformance in Q2 and increased guidance. A $15 billion share repurchase authorization is also in play.

Via MarketBeat

Topics Intellectual Property

Nasdaq Futures Rise As Focus Turns To Tesla, Netflix Q2 Prints: Analyst Says Earnings Need Some 'Heavy Lifting' For Sustained Rally ↗

July 19, 2023

Via Benzinga

NBCUniversal's Peacock Raises Prices First Time Since Launch, Warren Buffett Sells Majority of Activision Blizzard Stake Before Microsoft Deal Approval, Novartis Launches $15B Share Buyback: Today's Top Stories ↗

July 18, 2023

Wall Street Journal

Via Benzinga

Novartis Q2 Earnings: Company Lifts Outlook, Launches $15B Share Buyback, Maps Out Sandoz Spin-Off ↗

July 18, 2023

Novartis AG (NYSE: NVS) reported Q2 FY23 sales of $13.62 billion, up 7% Y/Y and 9% on constant currency, beating the consensus

Via Benzinga

Nasdaq, S&P 500 Futures Dip Ahead of Big Bank Earnings, Retail Sales Data: Why This Analyst Stays Cautious About Tech Sector ↗

July 18, 2023

Via Benzinga

Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday ↗

July 18, 2023

With U.S. stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Drug Maker Novartis Stock Shows Rising Relative Strength ↗

July 17, 2023

Novartis stock had its Relative Strength Rating upgraded to 73 Monday -- a nice improvement, but still shy of the preferred 80-plus score.

Via Investor's Business Daily

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

59 60 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.